Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EEF2K | O00418 | 1/20 | 0.46 |
| ▸ | PLK1 | P53350 | 1/20 | 0.46 |
| ▸ | PLK2 | Q9NYY3 | 1/20 | 0.46 |
| ▸ | STAT3 | P40763 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | RECQL | P46063 | 3/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 3/20 | 0.34 |
| ▸ | GAA | P10253 | 3/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | BLM | P54132 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.34 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.34 |
| ▸ | GSR | P00390 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL57290 | 0.82 | MEN1 (0.56) | ALDH1A1MAPTMEN1KMT2AHPGD | |
| P-Xyloquinone SCHEMBL49964 | 0.82 | PLK1 (0.60) | EEF2KPLK1PLK2STAT3ALDH1A1 | |
| SCHEMBL7897027 | 0.80 | ALDH1A1 (0.41) | EEF2KPLK1PLK2STAT3ALDH1A1 | |
| SCHEMBL1274862 | 0.77 | MAPT (0.42) | ALDH1A1MAPTMEN1KMT2AHPGD | |
| SCHEMBL11245633 | 0.77 | EEF2K (0.37) | EEF2KPLK1PLK2STAT3ALDH1A1 | |
| SCHEMBL14507718 | 0.71 | PLK1 (0.50) | EEF2KPLK1PLK2STAT3ALDH1A1 | |
| Benzoquinone SCHEMBL6026862 | 0.71 | ALDH1A1 (0.68) | ALDH1A1MAPTMEN1KMT2AHPGD | |
| SCHEMBL4911549 | 0.68 | MEN1 (0.47) | ALDH1A1MAPTMEN1KMT2AHPGD | |
| SCHEMBL3624714 | 0.68 | ALDH1A1 (0.50) | EEF2KPLK1PLK2STAT3ALDH1A1 | |
| SCHEMBL8664716 | 0.67 | MEN1 (0.48) | ALDH1A1MAPTMEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119977819-A | Organic electric energy transfer eutectic crystal with near infrared light thermal characteristics and preparation method of light heat storage fiber thereof | 苏州大学 | 2025-05-13 | — | — | CN | claimed |
| CN-113648293-B | Application of p-benzoquinone and/or p-benzoquinone derivative in preparation of novel coronavirus resistant medicine | 山东达因海洋生物制药股份有限公司 | 2022-07-05 | — | — | CN | claimed |
| CN-113648293-A | Application of p-benzoquinone and/or p-benzoquinone derivative in preparation of novel coronavirus resistant medicine | 山东达因海洋生物制药股份有限公司 | 2021-11-16 | — | — | CN | claimed |
| EP-1865915-A1 | ANTIMICROBIAL AGENTS | Syntopix limited (GB) | 2007-12-19 | — | — | EP | claimed |
| WO-2006100496-A1 | ANTIMICROBIAL AGENTS | SYNTOPIX LIMITED (GB) | 2006-09-28 | — | — | WO | claimed |
| CN-119977819-A | Organic electric energy transfer eutectic crystal with near infrared light thermal characteristics and preparation method of light heat storage fiber thereof | 苏州大学 | 2025-05-13 | — | — | CN | disclosed |
| CN-119985814-A | On-site water sample collection device and method based on solid phase extraction technology | 苏州市吴江区疾病预防控制中心 | 2025-05-13 | — | — | CN | disclosed |
| US-20250068074-A1 | NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, PRODUCTION METHOD FOR POLYIMIDE, PRODUCTION METHOD FOR CURED RELIEF PATTERN, AND SEMICONDUCTOR DEVICE | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-02-27 | — | — | US | disclosed |
| US-12174539-B2 | Negative photosensitive resin composition, production method for polyimide, production method for cured relief pattern, and semiconductor device | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-12-24 | — | — | US | disclosed |
| CN-118363270-A | Negative photosensitive resin composition, method for producing cured relief pattern, and semiconductor device | 旭化成株式会社 | 2024-07-19 | — | — | CN | disclosed |
| US-20220291585-A1 | NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, PRODUCTION METHOD FOR POLYIMIDE, PRODUCTION METHOD FOR CURED RELIEF PATTERN, AND SEMICONDUCTOR DEVICE | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2022-09-15 | — | — | US | disclosed |
| CN-113648293-B | Application of p-benzoquinone and/or p-benzoquinone derivative in preparation of novel coronavirus resistant medicine | 山东达因海洋生物制药股份有限公司 | 2022-07-05 | — | — | CN | disclosed |
| EP-1865915-A1 | ANTIMICROBIAL AGENTS | Syntopix limited (GB) | 2007-12-19 | — | — | EP | disclosed |
| WO-2006100496-A1 | ANTIMICROBIAL AGENTS | SYNTOPIX LIMITED (GB) | 2006-09-28 | — | — | WO | disclosed |
| EP-1416931-A1 | INHIBITORS OF POLYQ-AGGREGATION | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2004-05-12 | — | — | EP | disclosed |
| WO-2003015772-A1 | INHIBITORS OF POLYQ-AGGREGATION | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2003-02-27 | — | — | WO | disclosed |
| US-20020002286-A1 | Solid-phase process for making indole compounds | KETCHA DANIEL MICHAEL (US) | 2002-01-03 | — | — | US | disclosed |
| WO-2001058870-A2 | SOLID-PHASE PROCESS FOR MAKING INDOLE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2001-08-16 | — | — | WO | disclosed |
| US-4588810-A | Basic triphendioxazine dyestuffs | BAYER AKTIENGESELLSCHAFT (DE) | 1986-05-13 | — | — | US | disclosed |
| EP-0148390-A2 | Basic triphendioxazine dyes, their manufacture and their use | BAYER AG (DE) | 1985-07-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020002286-A1 | Solid-phase process for making indole compounds | AADAT, IDO1, IDO2 | EEF2K 146/4885PLK1 589/4885PLK2 310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.